641 episodes

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.

Psychedelics Today Psychedelics Today

    • Science
    • 4.3 • 6 Ratings

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.

    PT525 – Women and Psychedelics: History's Untold Stories, with Erika Dyck

    PT525 – Women and Psychedelics: History's Untold Stories, with Erika Dyck

    In this episode of Vital Psychedelic Conversations, Johanna interviews Erika Dyck: author, professor, historian, Vital instructor, and research chair in the History of Health & Social Justice at the University of Saskatchewan.
    Dyck talks about the book she co-edited: Women and Psychedelics: Uncovering Invisible Voices, which was released in March as a Chacruna anthology, and collects pieces from several different authors highlighting the untold or lesser known stories from women throughout psychedelic history. Albert Hofmann was the first person to intentionally ingest LSD, but who was the first woman to do so? Who were the women assisting in research or sitting with experiencers in the early days who never got the credit for their contributions? Who were the women supporting some of the biggest psychedelic names in history?
    She talks about:
    The contrast in societal attitudes towards psychedelic exploration based on stereotypical gender roles Some of her favorite stories from the book, including a woman diagnosed with manic depression becoming one of the first guides in LSD trials The use of psychedelics in pregnancy and birthing practices across other cultures Traditional gender attributes: Are women more wired to care for others? Is there something about the psychedelic experience that’s inherently feminine? The importance of moving past the gender binary and implementing more diversity in research – with the challenge of needing to universalize medicine at the same time and more!

    For links, head to the show notes page.

    • 1 hr 6 min
    PT524 – Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access, with Lia Mix, LMFT, CPTR

    PT524 – Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access, with Lia Mix, LMFT, CPTR

    In this episode, Joe interviews Lia Mix, LMFT, CPTR: founder and CEO of Delphi, a consulting firm dedicated to the healthy growth of the psychedelic movement.
    After many years of working in community mental health and 15 years in the commercial health insurance industry (where she helped to establish coverage for autism), Mix was one of the first graduates of CIIS’s training program, and after a very distinct MDMA-assisted therapy session, she wondered: “How can I be of service?” She’s since helped to launch The Board of Psychedelic Medicines and Therapies, the American Psychedelic Practitioners Association, and Enthea, and is working every day toward a more unified and uniform psychedelic space, with healthcare frameworks, official boards and certifications, consumer protections, and a general consensus that this is our responsibility to manage – not some outside regulator’s. So how can we, as a scattered psychedelic community, come together?
    She discusses:
    Her path to psychedelics and how nobody was talking about how to bring psychedelics into healthcare The need for a unified code of ethics for any practitioner of psychedelic therapy The FDA, Lykos Therapeutics, and how the recent advisory committee’s recommendations on MDMA-assisted psychotherapy were largely based on fear How there actually is a lot of financial possibility if we can all agree on what is absolutely essential right now and more!

    For links, head to the show notes page.

    • 1 hr 8 min
    PT523 – Self-Care, Destabilization, and the Holistic Nature of Psychedelics, with Kaitlin Roberson & Dr. Michele Cox, DO

    PT523 – Self-Care, Destabilization, and the Holistic Nature of Psychedelics, with Kaitlin Roberson & Dr. Michele Cox, DO

    In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel therapies for chronic pain; and Dr. Michele Cox, DO: current Vital student, veteran, physician, and co-founder of LifeBloom, a brand new company focusing on bringing community and connection into women’s healthcare.
    They talk about their work: Roberson’s research on trauma and chronic pain, and why she feels that working in the pharma industry is a calling; and Cox’s framework as an osteopath, the value she’s found in touch and connection, and how she explains to clients what to expect when undergoing ketamine treatment.
    They discuss:
    Why psychedelics are such useful interventions The body’s ability to tell us what’s wrong, as long we’re listening The destabilization that can occur after a big experience: If you don’t have a good support system, is it really the right time? Self-care and our tendency to never feel like we’re good enough How there is energy in everything and we should all recognize that more And, as Vital students, they talk about what they hoped to get out of Vital and how it delivered more than expected. If you’re just discovering Vital, be sure to check out the website and fill out an application. Secure your spot and take advantage of the Early Bird discount!

    For links, head to teh show notes page. 

    • 1 hr 17 min
    PT522 – An Inside look at the FDA and Early Drug Development, with Dr. Amanda Holley

    PT522 – An Inside look at the FDA and Early Drug Development, with Dr. Amanda Holley

    In this episode, Joe interviews Dr. Amanda Holley: pharmacologist and regulatory consultant in nonclinical drug development, and previously a nonclinical pharmacology/toxicology reviewer at the FDA.
    With Lykos Therapeutics working towards FDA approval of MDMA-assisted psychotherapy for PTSD, ICER (Institute for Clinical and Economic Review) recently published its draft evidence report, concluding that they couldn't endorse this modality. While disappointing to the psychedelic space, this report doesn't determine the FDA's official stance, and also really highlights a lot about how the FDA works, the knowledge gap between consumers and regulators, and how clinical studies should be designed in the future. Holley talks about the FDA's dedication to safety and data, and how, essentially, drug development comes down to a risk/benefit analysis. 
    She discusses: 
    Misconceptions about the FDA, especially related to psychedelics The path of a substance in early drug development and how breakthrough status works The complications with blinding psychedelics, the placebo effect, and how much therapy is a factor The contrast between productization and harm reduction: Should we be concerned with creating products, or understanding these substances better? How changing one molecule really does create a different drug and much more!

    For links, head to the show notes page. 

    • 1 hr 3 min
    PT521 – Community, Group Process, and Co-Creation: How to Build a Successful Retreat, with Alice Dommert & Kara Tremain, ACC

    PT521 – Community, Group Process, and Co-Creation: How to Build a Successful Retreat, with Alice Dommert & Kara Tremain, ACC

    In this episode of Vital Psychedelic Conversations, Kyle interviews two Vital graduates: Alice Dommert: certified breathwork facilitator and co-founder of retreat company, The Infinite Center; and Kara Tremain, ACC: somatic practitioner and growth and development coach.
    A huge part of Vital is the experiential aspect of attending a retreat. Students report that being part of a group process, feeling the power of the proper set and setting, taking a journey as both a sitter and experiencer, and separating from the world and connecting with each other has been one of the best parts of the program – even life-changing. With Dommert behind 13 Vital retreats to date, she and Kyle dive into what they’ve learned in how to run a successful retreat.
    They discuss:
    Facilitator humility and how important it is for everyone to be on the same page How much additional activities can add to the experience (tea ceremonies, CrossFit, chanting, fireside chats) The importance of allowing enough time and space for everything, from personal time with facilitators to possible issues Co-creation and openness: What can facilitators and people coming to the retreat build together? How do we create the most meaningful time together? If you’re interested in Vital, applications are now open with an Early Bird discount! And if you want to attend a Vital retreat, we have a few spots left in two: a transpersonal breathwork retreat in Pennsylvania, July 9-14, and a cannabis + breathwork retreat in Agoura Hills, CA in October. Head to the Infinite Center’s website for details.

    For links, head to the show notes page. 

    • 1 hr 11 min
    PT520 – From the Eleusinian Mysteries to Modern Mysticism: The Role of Religion in the Psychedelic Experience, with Charles Stang

    PT520 – From the Eleusinian Mysteries to Modern Mysticism: The Role of Religion in the Psychedelic Experience, with Charles Stang

    In this episode, Joe interviews Charles Stang: Professor of Early Christian Thought and the Director of the Center for the Study of World Religions at Harvard Divinity School.
    The Center was created to gain a better understanding of world religions by bringing scholars from their respective countries to study and live alongside Divinity School students. As students and Stang started to become interested in psychedelics, a zoom series, "Psychedelics and the Future of Religion," began, and the school just hosted their second conference, "Psychedelic Intersections: Cross Cultural Manifestations of the Sacred." Next year's Psychedelics and Spirituality conference will take place February 15, 2025. 
    He discusses: 
    Harvard's psychedelic history, and why it's important to not erase the past out of the interest of presumed legitimacy How people are consistently having extraordinary experiences with psychedelics, but not always with religion: Are people becoming less (or more) religious? The Immortality Key, the Eleusinian mysteries, and psychedelic enthusiasts' need to connect Christianity with psychedelics Psychedelics and other mystery religions, like Hermeticism and Mithraism Why religion is important to so many people, and how it helps us understand the "more-than-human"  and much more.

    For links, head to the show notes page.

    • 1 hr 24 min

Customer Reviews

4.3 out of 5
6 Ratings

6 Ratings

Jsgsodh ,

A podcast ran by experts

Kyle and Joe are extremely knowledgeable within the psychedelic sphere and they get some really great guests. If you’re interested in psychedelics, this is the best podcast.

Top Podcasts In Science

Abels tårn
NRK
Jøss‽
plingplong
Rekommandert
HENRI & Acast
Psykologipodcasten Synapsen
Psykologipodcasten Synapsen
Smart forklart
SINTEF
Making Sense with Sam Harris
Sam Harris

You Might Also Like

The Psychedelic Podcast
Third Wave
Psychedelic Therapy Frontiers
Numinus
Back from the Abyss: Psychiatry in Stories
Craig Heacock MD
Mushroom Revival Podcast
Alex Dorr
The Hamilton Morris Podcast
Hamilton Morris
Psychedelic Salon
Lorenzo Hagerty